Metraipolis › archive › dc_5ce06df3cb08

Transmembrane lectins in cancer immunity: emerging drivers of myeloid-mediated immunosuppression — Europe PMC PMID:42774833

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42774833
DOI: 10.3389/fimmu.2026.1952520
License (as archived): solo-consultazione
Archived: 2026-10-15T22:43:45.133Z
SHA-256 of the archived text: 9d75d0a6c4fd7396b9e98e8c774427562c3fa395ec03030473f6b3b92f22ed3f
Stable URL of this page: https://metraipolis.com/documento/dc_5ce06df3cb08

How to cite

Transmembrane lectins in cancer immunity: emerging drivers of myeloid-mediated immunosuppression — Europe PMC PMID:42774833 — Europe PMC (en), https://europepmc.org/article/MED/42774833 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ce06df3cb08 (Metraipolis archive dc_5ce06df3cb08, sha256 9d75d0a6c4fd7396b9e98e8c774427562c3fa395ec03030473f6b3b92f22ed3f)

BibTeX

@misc{dc5ce06df3cb08,
  title = {Transmembrane lectins in cancer immunity: emerging drivers of myeloid-mediated immunosuppression — Europe PMC PMID:42774833},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42774833},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ce06df3cb08; sha256 9d75d0a6c4fd7396b9e98e8c774427562c3fa395ec03030473f6b3b92f22ed3f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42774833. Agents can read the archived copy with the MCP tool read_document.